US Patent Issued to PHARMABLOCK SCIENCES (NANJING) on Sept. 8 for "CDK9 inhibitor and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,192, issued on Sept. 8, was assigned to PHARMABLOCK SCIENCES (NANJING) INC. (Nanjing, China).

"CDK9 inhibitor and use thereof" was invented by Zuozhong Peng (Nanjing, China), Jilin Jia (Nanjing, China), Jiaqi Hu (Nanjing, China), Qian Cui (Nanjing, China), Yizhou Wu (Nanjing, China), Yunfei Yi (Nanjing, China), Qiuhong Chen (Nanjing, China) and Jie Wang (Nanjing, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are a compound of formula (I) or a tautomer, a mesomer, a raceme, an enantiomer, a diastereoisomer, or a pharmaceutically acceptable salt thereof, and the use thereof in the preparation of drugs for diseases mediated by CDK9."

T...